{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:01Z","timestamp":1761895801145},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/pap.0000000000000010","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T09:50:03Z","timestamp":1391766603000},"page":"138-143","source":"Crossref","is-referenced-by-count":19,"title":["Uveal Melanoma"],"prefix":"10.1097","volume":"21","author":[{"given":"Lynn","family":"Schoenfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/eye.2012.237","article-title":"The pathology of ocular cancer.","volume":"27","author":"Eagle","year":"2013","journal-title":"Eye"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9394(83)90066-1","article-title":"A histopathologic study of 716 unselected eyes in patients with cancer at the time of death.","volume":"95","author":"Nelson","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival.","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9394(73)90003-2","article-title":"Benign nevi and malignant melanomas of the choroid.","volume":"76","author":"Ganley","year":"1973","journal-title":"Am J Ophthalmol"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/112067219600600423","article-title":"Dysplastic nevi are a risk factor for uveal melanoma.","volume":"6","author":"Hammer","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","article-title":"Uveal melanoma: epidemiologic aspects.","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000331042","article-title":"FNA cytology of ophthalmic tumors.","volume":"21","author":"Singh","year":"2012","journal-title":"Monogr Clin Cytol"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-27492013000200004","article-title":"Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.","volume":"76","author":"Augsburger","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma.","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/1097-0142(19901001)66:7<1596::AID-CNCR2820660726>3.0.CO;2-6","article-title":"Clinical prognostic factors in patients with posterior uveal malignant melanoma.","volume":"7","author":"Augsburger","year":"1990","journal-title":"Cancer"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/eye.2011.272","article-title":"Differences in uveal melanomas between men and women from the British Isles.","volume":"26","author":"Damato","year":"2012","journal-title":"Eye"},{"key":"R26-7-20210202","first-page":"131","article-title":"Malignant melanotic tumors of the eye. A study of histologic types in 111 cases.","volume":"36","author":"Callender","year":"1931","journal-title":"Trans Am Acad Ophthalmo Otolaryngol"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/eop.11.45","article-title":"Role of macrophages in uveal melanoma.","volume":"6","author":"Herwig","year":"2011","journal-title":"Expert Rev Ophthalmol"},{"key":"R37-7-20210202","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jnci\/82.22.1765","article-title":"Nonrandom chromosomal abnormalities in primary uveal melanoma.","volume":"82","author":"Prescher","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R46-7-20210202","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res"},{"key":"R55-7-20210202","first-page":"3032","article-title":"Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway.","volume":"59","author":"Parrella","year":"1999","journal-title":"Cancer Res"},{"key":"R56-7-20210202","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2217\/14796694.4.5.629","article-title":"Emerging insights into the molecular pathogenesis of uveal melanoma.","volume":"4","author":"Landreville","year":"2008","journal-title":"Future Oncol"},{"key":"R58-7-20210202","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification.","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R61-7-20210202","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-07-5144","article-title":"A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.","volume":"14","author":"Onken","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R62-7-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-148X.2012.00979.x","article-title":"The genetics of uveal melanoma: an emerging framework for targeted therapy.","volume":"25","author":"Harbour","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"R69-7-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000328254","article-title":"Ruthenium-106 brachytherapy.","volume":"49","author":"Peer","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"R73-7-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","article-title":"Effectiveness of treatments for metastatic uveal melanoma.","volume":"148","author":"Augsburger","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R78-7-20210202","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1167\/iovs.12-10365","article-title":"Gender differences in clinical presentation and prognosis of uveal melanoma.","volume":"54","author":"Zloto","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:38:36Z","timestamp":1620967116000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201403000-00007"}},"subtitle":["A Pathologist\u2019s Perspective and Review of Translational Developments"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000010","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}